Ketamine-assisted Psychotherapy (KAP) for Patients With Existential Distress Associated With Non-operable GI Cancers
Status:
Recruiting
Trial end date:
2025-11-15
Target enrollment:
Participant gender:
Summary
The goal of this open-label clinical trial is to assess the feasibility of Ketamine-assisted
psychotherapy (KAP) studies for adults with non-operable GI cancers suffering with
existential distress. The main questions it aims to answer are:
- Is it feasible to conduct a KAP study with this population?
- What is the safety and tolerability of KAP in this population?
- How prevalent is existential distress in this population?
Participants will undergo KAP administered as standard of care at the HMHI Park City
Ketamine-Assisted Psychotherapy Clinic and will complete health assessments over the course
of the study, as well as during the therapy.